Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

Cigna subsidiary Express Scripts Inc. claimed the Federal Trade Commission's July interim report—which claims middlemen have driven up prescription drug costs and exacerbated independent pharmacies—is ...

The agreement includes sweeping changes for Cigna’s PBM, including no longer preferring expensive drugs over cheaper ...

Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...

According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...

Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...